Page last updated: 2024-11-04

sulforaphane and Sarcopenia

sulforaphane has been researched along with Sarcopenia in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.

Research Excerpts

ExcerptRelevanceReference
"To explore the effects and molecular mechanisms of sulforaphane (SFN) on sepsis-associated inflammation and sarcopenia."8.31Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. ( Gan, L; Liu, M; Teng, Z; Wang, M; Wu, X; Xu, W; Zhang, Y, 2023)
"To explore the effects and molecular mechanisms of sulforaphane (SFN) on sepsis-associated inflammation and sarcopenia."4.31Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. ( Gan, L; Liu, M; Teng, Z; Wang, M; Wu, X; Xu, W; Zhang, Y, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wang, M3
Liu, M3
Xu, W3
Teng, Z3
Wu, X3
Gan, L3
Zhang, Y3
Bose, C1
Alves, I1
Singh, P1
Palade, PT1
Carvalho, E1
Børsheim, E1
Jun, SR1
Cheema, A1
Boerma, M1
Awasthi, S1
Singh, SP1

Other Studies

2 other studies available for sulforaphane and Sarcopenia

ArticleYear
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:4

    Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL

2023
Sulforaphane prevents age-associated cardiac and muscular dysfunction through Nrf2 signaling.
    Aging cell, 2020, Volume: 19, Issue:11

    Topics: Animals; Isothiocyanates; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Sarcopenia; Signal T

2020